Is Maltodextrin High FODMAP or Low FODMAP?

Standard digestible maltodextrin is classified as low FODMAP. It is a glucose polymer that your small intestine breaks down and absorbs before it ever reaches the large bowel, which means it does not undergo the bacterial fermentation that defines high-FODMAP carbohydrates. Researchers consider it so metabolically inert that it is the most common placebo used in clinical trials studying FODMAPs and irritable bowel syndrome. That said, recent evidence suggests maltodextrin is not as biologically neutral as once assumed, and a related product called resistant maltodextrin behaves quite differently in the gut.

Why Maltodextrin Is Classified as Low FODMAP

FODMAPs are short-chain carbohydrates that pass through the small intestine undigested, arrive in the colon, and get rapidly fermented by gut bacteria. That fermentation produces gas and draws water into the bowel, which is why high-FODMAP foods can trigger bloating, cramping, and diarrhea in sensitive people. The FODMAP family includes fructose in excess of glucose, lactose, fructans, galacto-oligosaccharides, and sugar alcohols like sorbitol and mannitol. For a carbohydrate to qualify as a FODMAP, it has to be poorly absorbed in the small intestine.

Maltodextrin fails that test in a good way, at least from a FODMAP perspective. It is made up of glucose units linked together in short chains, primarily with the same type of bond found in starch. Your digestive enzymes handle these bonds easily. The result is that maltodextrin gets broken down into individual glucose molecules and absorbed well before reaching the colon.¹ No delivery to the colon means no fermentation, no gas production, and no osmotic water pull. That is why Monash University, the group that developed the low-FODMAP diet, does not flag maltodextrin as a FODMAP concern.

How Maltodextrin Became the Default Placebo in Gut Research

If you read clinical trials on IBS, fructans, or the low-FODMAP diet, you will notice that maltodextrin shows up constantly on the control side of the experiment. Researchers need a substance that looks, tastes, and dissolves like the FODMAP they are testing but does not itself trigger gut symptoms. Maltodextrin fits the bill. It is a white, mildly sweet powder that blends easily into food or drink without drawing attention, and because it is considered fully digestible, it should not produce the kind of colonic fermentation that would muddy the results.

In one well-known crossover trial, children with IBS were given meals containing either fructans or maltodextrin at the same dose, up to 19 grams, for 72 hours. The maltodextrin arm served as the control, and the study found that fructans worsened symptoms in a subset of children compared to the maltodextrin period.² A separate trial in adults used the same approach, randomizing IBS patients to either fructo-oligosaccharides or maltodextrin supplements after a three-week low-FODMAP run-in period.³ In both cases, maltodextrin was treated as a biologically neutral comparator. That framing has been standard practice in the field for years.

A Measurement Problem That Confused the Literature

One reason maltodextrin sometimes appears in FODMAP discussions is a technical measurement artifact that inflated the apparent fructan content of products containing it. When researchers tried to measure fructans in enteral nutrition formulas using standard enzymatic assays, maltodextrin interfered with the results. It created dose-dependent artifacts in the fructan measurement, making it look like these products contained significant amounts of fructans when they may not have. In one analysis, applying an alternative assay that included additional enzymes to break down the maltodextrin first showed that the actual fructan content was less than 15 percent of what had been initially reported.⁴

Maltodextrin also coeluted with raffinose during liquid chromatography, meaning the two molecules came off the column at the same time and could not be distinguished from each other. That made it impossible to accurately estimate galacto-oligosaccharide content in maltodextrin-containing formulas.⁴ This matters because some early reports suggested certain tube-feeding products were unexpectedly high in FODMAPs, which raised concern among clinicians managing patients with sensitive guts. It turned out the maltodextrin was throwing off the readings. Newer analytical techniques, including high-performance anion-exchange chromatography, have been validated to separate and quantify individual FODMAP carbohydrates more accurately in complex food matrices.⁵

So if you have seen claims that certain processed foods or nutritional supplements are “high FODMAP” and maltodextrin is listed as a key ingredient, be aware that some of those early FODMAP measurements were inflated by the very presence of maltodextrin in the sample. The maltodextrin itself was not the FODMAP; it was distorting the measurement of other carbohydrates.

Why Maltodextrin May Not Be as Inert as Assumed

Here is where the story gets more complicated. Even though maltodextrin is not a FODMAP, a growing body of evidence suggests it is not biologically silent in the gut. A 2022 systematic review examined 70 randomized controlled trials that used maltodextrin as an oral placebo or control. About 60 percent of those trials reported that the maltodextrin arm itself produced measurable changes in gut physiology, microbial metabolites, or microbiome composition. Half of the trials that observed any maltodextrin effect found changes in the gut microbiome, including shifts in major bacterial groups and in species like Lactobacillus and Bifidobacterium.⁶

That is a striking finding for a substance treated as biologically inert for the purpose of clinical trial design. It does not mean maltodextrin is a FODMAP, since it is still digested in the small intestine rather than being fermented in the colon. But it does suggest that maltodextrin exerts effects on the gut through mechanisms other than the osmotic-fermentation pathway that defines FODMAPs.

Animal research has started to identify what some of those mechanisms might be. In mouse studies, maltodextrin consumption reduced the number of mucus-producing goblet cells in the intestinal lining and thinned the protective mucus layer that normally separates gut bacteria from the epithelium. This allowed bacteria to get closer to the intestinal wall.⁷ Further work found that maltodextrin triggered stress responses in goblet cells that led to reduced production of mucin-2, the main structural protein in intestinal mucus.⁸ Importantly, this effect was observed in intestinal cell cultures that had no bacteria or immune cells present, suggesting that maltodextrin acts directly on the gut lining rather than only through microbiome changes.

These are mouse and in-vitro studies, so it is not yet clear how well they translate to the amounts of maltodextrin a person would eat in real life. But for people with IBS or inflammatory bowel disease who are already dealing with a compromised gut barrier, the findings raise legitimate questions about whether maltodextrin deserves its reputation as a completely harmless ingredient, even if it technically remains low FODMAP.

Resistant Maltodextrin Is a Different Product Entirely

One source of confusion is that the term “maltodextrin” gets applied to two very different products. Standard digestible maltodextrin, the kind discussed above, is fully broken down in the small intestine. Resistant maltodextrin, sometimes labeled as soluble corn fiber or resistant dextrin, is produced through a different manufacturing process that rearranges the bonds between the glucose units. Those rearranged bonds resist digestion by human enzymes, so a significant fraction of the product survives to the colon and gets fermented by bacteria.

In laboratory fermentation experiments using human fecal samples, resistant maltodextrin was fermented slowly compared to dietary fibers like fructo-oligosaccharides, and only about 60 percent of it was broken down over 48 hours.⁹ That slow, partial fermentation makes resistant maltodextrin behave more like a prebiotic fiber than like a simple glucose source. It generates short-chain fatty acids in the colon and can produce gas, which means it has FODMAP-like effects even though it is not always formally classified as a FODMAP.

This distinction matters a great deal if you are reading ingredient labels. A protein bar listing “maltodextrin” as an ingredient almost certainly contains the standard digestible form and is not a FODMAP concern. But a product advertising “added fiber” from “soluble corn fiber” or “resistant maltodextrin” contains the partially indigestible version, which can cause gas and bloating in sensitive people. The two products have different regulatory classifications and serve different purposes in food manufacturing. Standard maltodextrin is a cheap carbohydrate filler and thickener; resistant maltodextrin is added to boost fiber content. If you are following a low-FODMAP diet, checking which type is in the product makes a real difference.

Where You Will Find Maltodextrin Hiding in Your Food

Maltodextrin is one of the most common food additives in the Western diet. It appears in an enormous range of processed foods, often in places you would not expect. Some of the categories where it shows up most frequently include:

Sauces and dressings: It acts as a thickener and gives body to low-fat products that would otherwise taste thin.
Sports drinks and supplements: It provides rapidly available glucose without the intense sweetness of sucrose or dextrose, making it popular in endurance nutrition.
Snack foods: Chips, crackers, and flavored coatings use maltodextrin as a carrier for powdered seasonings.
Medications and supplements: It serves as a filler and binder in tablets, capsules, and powdered supplements.
Instant soups and gravies: It improves mouthfeel and helps the product dissolve evenly in hot water.

Because maltodextrin is digestible and low FODMAP, its presence on an ingredient list is generally not a problem for someone on a low-FODMAP elimination diet. The concern, rather, is what else is in the product alongside it. Processed foods that contain maltodextrin often also contain onion powder, garlic powder, high-fructose corn syrup, inulin, or chicory root fiber, all of which are high FODMAP. The maltodextrin itself is not the culprit, but it keeps company with ingredients that are.

Wheat-Derived Maltodextrin and Gluten Worries

Maltodextrin can be produced from various starch sources, including corn, potato, rice, tapioca, and wheat. In the United States, corn-derived maltodextrin dominates the market, but wheat-derived versions are used in some European products. This understandably raises concerns for people who are avoiding both FODMAPs and gluten, since there is a substantial overlap between those populations.

The processing used to produce maltodextrin involves extensive hydrolysis, meaning the starch is broken down so thoroughly that the resulting product is almost entirely short glucose chains. Gluten proteins, which are responsible for celiac reactions, are largely removed or destroyed during this process. Regulatory agencies in both the US and Europe generally permit wheat-derived maltodextrin to be labeled gluten-free if it meets the threshold of fewer than 20 parts per million of gluten. That said, sensitivity varies, and some people with celiac disease prefer to avoid wheat-derived maltodextrin as a precaution. If the label says “maltodextrin” without specifying the source, contacting the manufacturer is the surest way to find out.

What the Placebo Problem Means for Future Research

The finding that maltodextrin produces measurable effects in a majority of the trials where it was used as a placebo has implications beyond individual dietary choices. If the control substance in a study is not truly inert, it becomes harder to detect the real effect of whatever treatment is being tested. Imagine a trial comparing a probiotic supplement to maltodextrin. If the maltodextrin itself shifts gut bacteria, the difference between the two groups will appear smaller than it actually is. That could lead researchers to conclude that the probiotic did not work, when really the placebo was partially mimicking the treatment.⁶

This does not mean all previous FODMAP trials are invalid. In studies comparing a known FODMAP like fructans against maltodextrin, the fructan arm still shows clearly worse symptoms, which tells us the effect of fructans is strong enough to show through even if the placebo is not perfectly neutral.² But it does mean that the magnitude of FODMAP effects in some studies may have been underestimated. Researchers in the field are now debating whether future gut-health trials should use a different placebo altogether, though finding a substance that truly does nothing in the gut turns out to be surprisingly difficult.

Practical Guidance if You Have IBS

If you are following a low-FODMAP elimination diet, standard maltodextrin does not need to go on your avoid list. It is digested and absorbed like starch, and it does not contribute to the osmotic and fermentation effects that define FODMAP sensitivity. You do not need to scrutinize every ingredient panel for it.

What is worth paying attention to is context. If you eat a processed food containing maltodextrin and experience symptoms, investigate the other ingredients before blaming the maltodextrin. Garlic powder, onion powder, honey, agave, inulin, chicory root extract, and high-fructose corn syrup are all common in the same products and are all high FODMAP. Maltodextrin is more likely an innocent bystander than the trigger.

If you notice that products with “resistant maltodextrin,” “soluble corn fiber,” or “resistant dextrin” on the label seem to bother you, that is a different situation. Those partially indigestible fibers reach the colon and get fermented, and their effects can overlap with FODMAP symptoms even though they are not always formally classified in the FODMAP framework. During the strict elimination phase of a low-FODMAP diet, it is reasonable to avoid them and reintroduce them later during the challenge phase to see how you tolerate them.

For people with inflammatory bowel disease rather than IBS, the animal research on maltodextrin and the mucus barrier is worth knowing about, though it is too early for firm dietary recommendations based on mouse data alone. If you are in remission and trying to minimize anything that might irritate your gut lining, discussing maltodextrin intake with your gastroenterologist is not unreasonable, especially if you consume large amounts through sports nutrition products or processed foods. The research is still evolving, and the gap between what we know from animal models and what has been confirmed in humans remains wide.